Statements

2023

SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD) - January 18, 2023

2022

Statement from Assistant Secretary for Mental Health and Substance Use Miriam Delphin-Rittmon, Ph.D. on Successful Transition to 988 - July 22, 2022

Olmstead Anniversary Statement from Assistant Secretary for Mental Health and Substance Use Miriam E. Delphin-Rittmon, Ph.D. - June 22, 2022

Statement by HHS Secretary Xavier Becerra and ONDCP Director Rahul Gupta - February 9, 2022

Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay - January 12, 2022

2021

International Overdose Awareness Day Statement from Assistant Secretary for Mental Health and Substance Use Miriam E. Delphin-Rittmon, Ph.D. - August 31, 2021

Joint Statement of Commitment to Continuing Cooperation on the National Judicial Task Force to Examine State Courts’ Response to Mental Illness - July 16, 2021

Statement on 42 CFR Part 2 Amendments Process - April 9, 2021